Company profile: Acron Genomics
1.1 - Company Overview
Company description
- Provider of novel biotechnology platform development and commercialization in the life sciences, and of the introduction and development of promising new pharmaceutical compounds. U.S. publicly traded (OTC Markets/AGNM).
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Acron Genomics
Adona Medical
HQ: United States
Website
- Description: Provider of heart failure management systems, including the Adona Interatrial Shunt with integrated bi-atrial pressure monitoring enabling individualized shunting; bi-atrial pressure sensors delivering direct LA and RA readings with >5 automated readings/day; shape memory Nitinol shunt lumen adjustment technology; and the Adona Induction Catheter for non-contact inductive energy transfer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adona Medical company profile →
Atritech
HQ: United States
Website
- Description: Provider of proprietary technology focused on replacing long-term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke, including the WATCHMAN Left Atrial Appendage Closure Technology. Private company founded in 2000 and based in Minneapolis, Minnesota.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atritech company profile →
Cardiac Dimensions
HQ: United States
Website
- Description: Provider of tools and techniques for the treatment of heart failure and related conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiac Dimensions company profile →
Maya Medical
HQ: United States
Website
- Description: Provider of a novel percutaneous catheter for the treatment of hypertension in patients who are unable to effectively control blood pressure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Maya Medical company profile →
Vantis Vascular
HQ: United States
Website
- Description: Provider of vascular intervention technology for complex arteries, offering the DuoPRO™ system to navigate tortuous, calcific, and stented arteries and deliver therapeutic devices to distal coronary or peripheral anatomies. Features include the Seamless Profile low-profile tapered design, an inner microcatheter with pushability and atraumatic tip, and an outer delivery catheter enabling smooth navigation and delivery to distal lesions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vantis Vascular company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Acron Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Acron Genomics
2.2 - Growth funds investing in similar companies to Acron Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Acron Genomics
4.2 - Public trading comparable groups for Acron Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →